Jones Financial Companies
ABVX

Jones Financial Companies’s Abivax ABVX Stock Holding History

Jones Financial Companies’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Buy
4,070
+4,057
+31,208% +$480K ﹤0.01% 2130
2025
Q4 		$1.75K Hold
13
– – ﹤0.01% 3861
2025
Q3 		$1.08K Buy
+13
New +$797 ﹤0.01% 3871

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Jones Financial Companies's ABVX Position: Q1 2026 in Review

Jones Financial Companies increased its Abivax (ABVX) stake by 31,208% in Q1 2026, buying an estimated $480K and bringing the position to 4,070 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

Jones Financial Companies first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Jones Financial Companies held 4,070 shares of Abivax worth $417K as of Q1 2026.
  • Jones Financial Companies bought 4,057 Abivax shares in Q1 2026, an estimated $480K.
  • Abivax made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #2130 holding.
  • Jones Financial Companies first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.